BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 29281997)

  • 1. Meta-analysis of the safety of voriconazole in definitive, empirical, and prophylactic therapies for invasive fungal infections.
    Xing Y; Chen L; Feng Y; Zhou Y; Zhai Y; Lu J
    BMC Infect Dis; 2017 Dec; 17(1):798. PubMed ID: 29281997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of voriconazole in immunocompromised patients: systematic review and meta-analysis.
    Rosanova MT; Bes D; Serrano Aguilar P; Sberna N; Lede R
    Infect Dis (Lond); 2018 Jul; 50(7):489-494. PubMed ID: 29262742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trough concentration of voriconazole and its relationship with efficacy and safety: a systematic review and meta-analysis.
    Jin H; Wang T; Falcione BA; Olsen KM; Chen K; Tang H; Hui J; Zhai S
    J Antimicrob Chemother; 2016 Jul; 71(7):1772-85. PubMed ID: 26968880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of voriconazole therapeutic drug monitoring: a meta-analysis.
    Luong ML; Al-Dabbagh M; Groll AH; Racil Z; Nannya Y; Mitsani D; Husain S
    J Antimicrob Chemother; 2016 Jul; 71(7):1786-99. PubMed ID: 27165788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal trough concentration of voriconazole with therapeutic drug monitoring in children: A systematic review and meta-analysis.
    Hanai Y; Hamada Y; Kimura T; Matsumoto K; Takahashi Y; Fujii S; Nishizawa K; Takesue Y
    J Infect Chemother; 2021 Feb; 27(2):151-160. PubMed ID: 33376032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing the safety and efficacy of voriconazole versus posaconazole in the prevention of invasive fungal infections in high-risk patients with hematological malignancies.
    Hachem R; Assaf A; Numan Y; Shah P; Jiang Y; Chaftari AM; Raad II
    Int J Antimicrob Agents; 2017 Sep; 50(3):384-388. PubMed ID: 28694233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of isavuconazonium sulfate, voriconazole, and posaconazole for the management of invasive fungal infections in an academic medical center.
    Van Matre ET; Evans SL; Mueller SW; MacLaren R; Fish DN; Kiser TH
    Ann Clin Microbiol Antimicrob; 2019 Mar; 18(1):13. PubMed ID: 30894179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic antifungal prophylaxis after hematopoietic stem cell transplantation: a meta-analysis.
    Ziakas PD; Kourbeti IS; Mylonakis E
    Clin Ther; 2014 Feb; 36(2):292-306.e1. PubMed ID: 24439393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review and meta-analysis of efficacy and safety of isavuconazole for the treatment and prophylaxis of invasive fungal infections.
    Kato H; Hagihara M; Asai N; Umemura T; Hirai J; Mori N; Yamagishi Y; Iwamoto T; Mikamo H
    Mycoses; 2023 Sep; 66(9):815-824. PubMed ID: 37300337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newer antifungal agents micafungin and voriconazole for fungal infection prevention during hematopoietic cell transplantation: a meta-analysis.
    Xu SX; Shen JL; Tang XF; Feng B; Xu HQ
    Eur Rev Med Pharmacol Sci; 2016; 20(2):381-90. PubMed ID: 26875911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic drug monitoring and safety of intravenous voriconazole formulated with sulfobutylether β-cyclodextrin in haematological patients with renal impairment.
    Kim SH; Kwon JC; Park C; Han S; Yim DS; Choi JK; Cho SY; Lee HJ; Park SH; Choi SM; Choi JH; Yoo JH; Lee DG; Lee JW
    Mycoses; 2016 Oct; 59(10):644-51. PubMed ID: 27324913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical study on empirical and diagnostic-driven (pre-emptive) therapy of voriconazole in severe aplastic anaemia patients with invasive fungal disease after intensive immunosuppressive therapy.
    Wu Y; Yan L; Wang H; Liu H; Xing L; Fu R; Shao Z
    Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):949-954. PubMed ID: 33219473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination antifungals as an effective means of salvage in paediatric leukaemia patients with invasive fungal infections.
    Meena JP; Gupta AK; Jana M; Seth R
    Indian J Med Microbiol; 2019; 37(1):109-112. PubMed ID: 31424020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating a voriconazole dose modification guideline to optimize dosing in patients with hematologic malignancies.
    Perreault S; McManus D; Anderson A; Lin T; Ruggero M; Topal JE
    J Oncol Pharm Pract; 2019 Sep; 25(6):1305-1311. PubMed ID: 29996736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voriconazole plus terbinafine combination antifungal therapy for invasive Lomentospora prolificans infections: analysis of 41 patients from the FungiScope® registry 2008-2019.
    Jenks JD; Seidel D; Cornely OA; Chen S; van Hal S; Kauffman C; Miceli MH; Heinemann M; Christner M; Jover Sáenz A; Burchardt A; Kemmerling B; Herbrecht R; Steinmann J; Shoham S; Gräber S; Pagano L; Deeren D; Aslam S; Taplitz R; Revankar SG; Baddley J; Mehta SR; Reed S; Slavin MA; Hoenigl M
    Clin Microbiol Infect; 2020 Jun; 26(6):784.e1-784.e5. PubMed ID: 31972317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of Invasive Fungal Infection in Childhood Acute Lymphoblastic Leukemia with Amphotericin B and Voriconazole].
    Yi XL; Mao Q; Jiang Y; Guo XB; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec; 25(6):1627-1630. PubMed ID: 29262887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.
    Maertens JA; Raad II; Marr KA; Patterson TF; Kontoyiannis DP; Cornely OA; Bow EJ; Rahav G; Neofytos D; Aoun M; Baddley JW; Giladi M; Heinz WJ; Herbrecht R; Hope W; Karthaus M; Lee DG; Lortholary O; Morrison VA; Oren I; Selleslag D; Shoham S; Thompson GR; Lee M; Maher RM; Schmitt-Hoffmann AH; Zeiher B; Ullmann AJ
    Lancet; 2016 Feb; 387(10020):760-9. PubMed ID: 26684607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empiric treatment against invasive fungal diseases in febrile neutropenic patients: a systematic review and network meta-analysis.
    Chen K; Wang Q; Pleasants RA; Ge L; Liu W; Peng K; Zhai S
    BMC Infect Dis; 2017 Feb; 17(1):159. PubMed ID: 28219330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful challenge of voriconazole in a patient with posaconazole-associated minor drug eruption: A case report.
    Weeraphon B; Vanichanan J; Usayaporn S
    J Clin Pharm Ther; 2020 Dec; 45(6):1486-1488. PubMed ID: 32686229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voriconazole for prophylaxis of invasive fungal infections after allogeneic hematopoietic stem cell transplantation.
    Marks DI; Liu Q; Slavin M
    Expert Rev Anti Infect Ther; 2017 May; 15(5):493-502. PubMed ID: 28335642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.